Intended for healthcare professionals

Rapid response to:

Practice NIHR Signals

Routine use of progesterone does not prevent miscarriage

BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l5721 (Published 08 November 2019) Cite this as: BMJ 2019;367:l5721

Editorial

NIHR’s research signals in The BMJ

Rapid Response:

Routine use of progesterone might also increase diabetes

A meta-analysis of clinical studies revealed that women who received supplemental 17-alpha hydroxyprogesterone caproate for the prevention of preterm birth had increased risk of developing gestational diabetes mellitus.
Reference
https://www.ajog.org/article/S0002-9378(19)30705-7/abstract

Competing interests: No competing interests

12 November 2019
Stavros Saripanidis
Consultant in Obstetrics and Gynaecology
Thessaloniki, Greece